CEBPA and acute myeloid leukemia: One of the C/EBPα-mutations in the AML blasts (sample #3) was a deletion of K313, not a duplication, and cells expressing this mutant showed only slightly elevated mRNA but a nearly threefold increase in p42 and an 11-fold increase in p30 C/EBPα (Fig. 4B–D).